1-8 of 8
Alvaro Urbano-Ispizua, MD PhD
Close
Sort by
Journal Articles

Efficacy of Eculizumab in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria in the International PNH Registry

Álvaro Urbano-Ispizua, MD PhD, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Marije Bartels, MD PhD, Christopher J. Patriquin, MD MSc, FRCPC, Britta Hoechsmann, MD, Alexey A. Maschan, MD, Amanda Wilson, PhD, Philippe Gustovic, MD, Hubert Schrezenmeier, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3614.
https://doi.org/10.1182/blood-2018-99-111306
Published: 2018
Journal Articles

Natural Killer Cells Transfer Antimicrobial and Antitumoral Histone H2AZ to Kill Multiple Myeloma Cells Contributing to Transmissible Cytotoxicity

Beatriz Martin-Antonio, PhD, Guillermo Suñe, PhD, Amer Najjar, PhD, Lorena Perez-Amill, Maria Velasco-de Andres, Francisco Lozano, Ester Lozano, Cristina Muñoz-Punedo, Carlos Fernández de Larrea, Alvaro Urbano-Ispizua, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2115.
https://doi.org/10.1182/blood.V128.22.2115.2115
Published: 2016
Journal Articles

Clinical Benefit of Eculizumab in Patients with No Transfusion History in the International Paroxysmal Nocturnal Hemoglobinuria Registry

Antonio Medina Almeida, MD PhD, Camille L. Bedrosian, MD, Alexander Cole, DSc, MPH, Petra Muus, MD PhD, Hubert Schrezenmeier, MD, Jeff Szer, MB, BS, FRACP, Alvaro Urbano-Ispizua, MD PhD, Wendell F. Rosse, MD
Journal: Blood
Blood (2015) 126 (23): 3340.
https://doi.org/10.1182/blood.V126.23.3340.3340
Published: 2015
Journal Articles

Cell-Cell Communication Between Multiple Myeloma (MM) Cells and Cord Blood Derived NK Cells (CB-NK) Regulates Both Tumor Cell Death and Tumor Cell Survival

Beatriz Martin-Antonio, PhD, Erica Serrano, Guillermo Suñe, PhD, Lorena Perez, Marcos Calderón, Jose María Estanyol, PhD, Amer Najjar, PhD, Clara Bueno, PhD, Carlos Fernandez de Larrea, Alvaro Urbano-Ispizua, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1787.
https://doi.org/10.1182/blood.V126.23.1787.1787
Published: 2015
Journal Articles

Genetic Variability In the Transcriptional Factor EP300 Strongly Influences the Clinical Outcome of Allogeneic Stem Cell Transplantation (Allo-SCT)

Beatriz Martin-Antonio, PhD, Rocio Cardesa, Isabel Álvarez, Francisco Márquez-Malaver, Alicia Báez, Magdalena Carmona, MD, Jose Falantes, Francesc fernandez-Aviles, Carmen Martinez, Montserrat Rovira, MD, Ildefonso Espigado, MD, PhD, Alvaro Urbano-Ispizua, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 527.
https://doi.org/10.1182/blood.V116.21.527.527
Published: 2010
Journal Articles

Low-Intensity Fludarabine, Cyclophosphamyde, Rituximab (FCR) as Front-Line Treatment for Follicular Lymphoma. Efficacy and Toxicity Profile of the Oral Versus Intravenous Administration.

Ana Marin-Niebla, MD, Eduardo Rios-Herranz, MD, Fáatima de la Cruz Vicente, Jr., MD, Paula Cerezuela, MD, Jose Francisco Falantes, MD, Mariluz Martino, MD, Ildefonso Espigado, Alvaro Urbano Ispizua, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2690.
https://doi.org/10.1182/blood.V114.22.2690.2690
Published: 2009
Journal Articles

Incidence of Neutropenia and Hypogammaglobulinemia and Correlation with the Infections Rate in Indolent Non-Hodgkin Lymphoma (NHL) Receiving Rituximab Maintenance.

Ana Marin-Niebla, MD, Eduardo Rios-Herranz, MD, Jose F. Falantes, MD, Mariluz Martino, MD, Ildefonso Espigado, MD PhD, Alvaro Urbano-Ispizua, MD PhD
Journal: Blood
Blood (2007) 110 (11): 4495.
https://doi.org/10.1182/blood.V110.11.4495.4495
Published: 2007
Journal Articles

Analysis of microRNA Patterns in Hodgkin’s Lymphoma (HL).

Alfons Navarro, PhD, Anna Gaya, MD, Aina Pons, PhD, Pau Abrisqueta, MD, Bernat Gel, PhD, Antonio Martinez, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Carmen Martinez, MD, PhD, Miquel Granell, MD, Rosa Artells, PhD, Sonia Jansa, PhD, Alvaro Urbano-Ispizua, MD, PhD, Emili Montserrat, MD, PhD, Mariano Monzo, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 474.
https://doi.org/10.1182/blood.V108.11.474.474
Published: 2006